We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,673.00
Bid: 1,674.00
Ask: 1,675.00
Change: 3.00 (0.18%)
Spread: 1.00 (0.06%)
Open: 1,661.50
High: 1,679.50
Low: 1,658.50
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Financials mixed as investor lock in profits

Fri, 22nd Jul 2011 14:18

The financial sector was mixed on Friday, despite rising strongly early on following yesterday's Eurozone deal to bailout Greece. Shares soared on Thursday after the region's leaders agreed a new aid package for Greece and an overhaul of the Eurozone sovereign rescue fund. While RBS bucked the trend amongst financials - with the part-nationalised bank gaining 2.36% to trade at 36.90p - other financial shares lost some of their earlier buoyancy as investors looked to lock in some profits following yesterday's gains. Lloyds and insurance peers Prudential, Old Mutual and Legal & General were prominent among the fallers.Aviva, however, rose higher after takeover rumours regarding the insurance firm resurfaced, citing two European peers (Allianz and Zurich Financial) to be potential suitors. Engineering peers IMI and Weir were among the top performers, gaining 3.48% and 1.93%, respectively.Silver mining giant Fresnillo, too, was a high riser tracking silver prices upwards. Silver futures were 2.52% up at $39.93 at 14:12 on Friday afternoon in London (09:31 in New York).Drugs giants AstraZeneca and GlaxoSmithKline fell into the red after UBS cut its rating on the European pharmaceutical sector from 'small overweight' to 'neutral', saying the defensive sector that benefited from the economic soft patch and the sovereign debt crisis will be hit by the turnaround in these lead indicators. Vodafone was firmer after reporting that revenue from its core business grew by 1.5% in the second quarter of 2011.Outsourcing giant Capita was in demand after the acquisition of the pensions administration and software business of NorthgateArinso for £27.5m.BCFTSE 100 - RisersIMI (IMI) 1,099.00p +3.48%Fresnillo (FRES) 1,687.00p +2.62%Royal Bank of Scotland Group (RBS) 36.90p +2.36%Capita Group (CPI) 700.00p +2.04%Weir Group (WEIR) 2,163.00p +1.93%Marks & Spencer Group (MKS) 360.50p +1.92%Vodafone Group (VOD) 164.25p +1.83%Vedanta Resources (VED) 1,881.00p +1.79%International Consolidated Airlines Group SA (IAG) 242.00p +1.77%WPP (WPP) 734.50p +1.66%FTSE 100 - FallersLloyds Banking Group (LLOY) 46.70p -1.82%Essar Energy (ESSR) 379.00p -1.30%Prudential (PRU) 689.50p -1.29%Old Mutual (OML) 130.00p -1.07%Legal & General Group (LGEN) 116.00p -1.02%Admiral Group (ADM) 1,572.00p -1.01%AstraZeneca (AZN) 3,061.50p -0.99%Rexam (REX) 380.70p -0.91%Investec (INVP) 503.50p -0.89%Amec (AMEC) 1,116.00p -0.80%
More News
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.